BRIEF-SynAct Pharma Signs First Commercial Partnership For Resomelagon

1

Oct 27 (Reuters) – SynAct Pharma AB: * SYNACT PHARMA SIGNS FIRST COMMERCIAL PARTNERSHIP FOR RESOMELAGON WITH LEADING BRAZILIAN PHARMACEUTICAL COMPANY * COLLABORATION BUILDS ON SYNACT'S ONGOING RESOVIR

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)